NBEO® Part 1 Full Length Test #1 - Ocular & General Pharmacology
Next
0 of 7 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Information
|
Optometry Board Practice Test for the NBEO® Part 1 Test #1 – Ocular & General Pharmacology This test is comprised of 7 items, which must be completed within 7 minutes. |
You have already completed the quiz before. Hence you can not start it again.
Exam is loading ...
You must sign in or sign up to start the exam.
You have to finish following exam, to start this exam:
Results
0 of 7 questions answered correctly
Your time:
Time has elapsed
You answered 0 of 0 (0) questions correct
| Average score |
|
| Your score |
|
Categories
- Not categorized 0%
- Biochemistry 0%
- General Pharmacology: Anti-Inflammatory Drugs 0%
- General Pharmacology: Anticoagulants 0%
- General Pharmacology: Antidepressants 0%
- General Pharmacology: Antifungal Drugs 0%
- General Pharmacology: Antihistamine Drugs 0%
- General Pharmacology: Antimicrobial Drugs 0%
- General Pharmacology: Autonomic drugs 0%
- General Pharmacology: Cardiovascular Drugs 0%
- General Pharmacology: CNS Drugs 0%
- General Pharmacology: Diabetes Drugs 0%
- General Pharmacology: Drugs of Abuse 0%
- General Pharmacology: Endocrine Drugs 0%
- General Pharmacology: Gastrointestinal Drugs 0%
- General Pharmacology: Genitourinary Drugs 0%
- General Pharmacology: Hypertensive Drugs 0%
- General Pharmacology: Respiratory Drugs 0%
- General Pharmacology: Tuberculosis Drugs 0%
- Gross Anatomy: Blood Supply 0%
- Gross Anatomy: Brain/Nervous System 0%
- Gross Anatomy: Lymphatics 0%
- Gross Physiology: Kidney 0%
- Gross Physiology: Pancreas 0%
- Histology + Ocular Anatomy 0%
- Immunology + Systemic Disease: Immunopathology 0%
- Immunology: Systemic Health 0%
- Microbiology 0%
- Neuroanatomy 0%
- Neuroscience: Neuroanatomy 0%
- Ocular Anatomy: Adnexa/Orbit 0%
- Ocular Anatomy: Conjunctiva + Orbit 0%
- Ocular Anatomy: Cornea 0%
- Ocular Anatomy: Eyelid 0%
- Ocular Anatomy: Iris 0%
- Ocular Anatomy: Lens 0%
- Ocular Anatomy: Ocular and Orbital Nerves 0%
- Ocular Anatomy: Optic Nerve 0%
- Ocular Anatomy: Orbit 0%
- Ocular Anatomy: Orbit/Blood Supply 0%
- Ocular Anatomy: Orbit/Extraocular Muscles 0%
- Ocular Anatomy: Retina 0%
- Ocular Anatomy: Uvea 0%
- Ocular Anatomy: Vitreous 0%
- Ocular and General Pharmacology 0%
- Ocular and General Pharmacology: CNS Drugs 0%
- Ocular Disease: Conjunctiva 0%
- Ocular Disease: Cornea 0%
- Ocular Disease: Cornea/Refractive Surgery 0%
- Ocular Disease: Episclera/Sclera/Anterior and Posterior Uvea 0%
- Ocular Disease: Glaucoma 0%
- Ocular Disease: Lens/Cataract/IOL Pre- and Post-op Care 0%
- Ocular Disease: Lids/Lashes/Lacrimal System 0%
- Ocular Disease: Neuro-Ophthalmic Disorder 0%
- Ocular Disease: Ocular Adnexa/Orbit/External Disease 0%
- Ocular Disease: Ocular Adnexa/Orbit/External Disease + Retina 0%
- Ocular Disease: Retina/Choroid 0%
- Ocular Disease: Trauma 0%
- Ocular Embryology and Development 0%
- Ocular Motility + Binocular Vision 0%
- Ocular Motility + Binocular Vision: Accommodation 0%
- Ocular Motility + Binocular Vision: Amblyopia 0%
- Ocular Motility + Binocular Vision: Ametropia 0%
- Ocular Motility + Binocular Vision: Fixation Disparity 0%
- Ocular Motility + Binocular Vision: Ocular Development 0%
- Ocular Motility + Binocular Vision: Ocular Motor Dysfunction 0%
- Ocular Motility + Binocular Vision: Vergence/OMD 0%
- Ocular Pharmacology 0%
- Ocular Pharmacology: Agents for Exudative ARMD 0%
- Ocular Pharmacology: Anti-Inflammatory Agents 0%
- Ocular Pharmacology: Anti-Inflammatory Drugs 0%
- Ocular Pharmacology: Antihistamines 0%
- Ocular Pharmacology: Antimicrobial Drugs 0%
- Ocular Pharmacology: Autonomic Drugs 0%
- Ocular Pharmacology: Glaucoma Agents 0%
- Ocular Pharmacology: Glaucoma Drugs 0%
- Ocular Pharmacology: Hyperosmotic Agents 0%
- Ocular Pharmacology: Preservatives 0%
- Ocular Pharmacology: Topical Anesthetics Drugs 0%
- Ocular Pharmacology: Topical Ocular Anesthetics 0%
- Ocular Pharmacology: Tuberculosis Drugs 0%
- Ocular Physiology: Aqueous 0%
- Ocular Physiology: Cornea 0%
- Ocular Physiology: Neuroanatomy 0%
- Ocular Physiology: Tears 0%
- Ophthalmic Optics 0%
- Ophthalmic Optics: Lasers 0%
- Optics: Contact Lenses 0%
- Optics: Low Vision 0%
- Systemic Disease: Autoimmune Disease 0%
- Systemic Disease: Demyelinating Disease 0%
- Systemic Disease: Diseases of Reproductive System 0%
- Systemic Disease: Endocrine System 0%
- Systemic Disease: Gastrointestinal System 0%
- Systemic Disease: Genetic Disease 0%
- Systemic Disease: Genetic Disorder 0%
- Systemic Disease: Genetic Disorders 0%
- Systemic Disease: Immunopathology 0%
- Systemic Disease: Inflammatory Disease 0%
- Systemic Disease: Integumentary System 0%
- Systemic Disease: Neuroanatomy 0%
- Systemic Disease: Neurodegenerative Disease 0%
- Systemic Disease: Vascular Disease 0%
- Systemic Disease: Vascular Disease/Neuroanatomy 0%
- Systemic Disease: Vasculitis Disorders 0%
- Visual Perception 0%
-
Based on your performance on this Optometry Board Part 1 Practice Test, you’re not yet ready for the NBEO® Part 1.
Keep your head up! Also, don’t focus on your estimated score, they mean essentially nothing at the start. Rarely does anyone start these exams and score well immediately, if that was the case then they wouldn’t even need to practice! These are ‘practice’ tests, meaning you’re practicing to improve your skills. If you continue to work hard and study, read and understand the solutions, practice with “OptometryBoards.com” daily and give it your best effort, we promise your score will improve. Review and learn for now, and the scores will come.
-The “OptometryBoards.com” Team
-
Congratulations! Based on your performance on this Optometry Board Part 1 Practice Test, you’re predicted to pass your NBEO® Part 1! Keep hammering away at our Optometry Board questions so that you can keep up the great work!
-The “OptometryBoards.com” Team
-
Question 1 of 7
1. Question
Which of the following is NOT considered a side effect of Tamoxifen?
CorrectE. All of the above traits are true. To recall, the 4 C’s of side effects: Clots, Cancer, Crystal, Corneal Whorl. Tamoxifen inhibits estradiol thereby reducing estrogen effects in the breast. Patients in remission must remain on this medication for up to 5 years after successful treatment.
IncorrectE. All of the above traits are true. To recall, the 4 C’s of side effects: Clots, Cancer, Crystal, Corneal Whorl. Tamoxifen inhibits estradiol thereby reducing estrogen effects in the breast. Patients in remission must remain on this medication for up to 5 years after successful treatment.
-
Question 2 of 7
2. Question
Which of the following medications is commonly used in the treatment of muscle spasms?
CorrectC. Cyclobenzaprine, also known as Flexeril, is a muscle relaxant used in treatment of muscle spasms. It works by decreasing somatic motor activity by inhibiting tonic activity of alpha and gamma neurons. Caution as this medication may cause Narrow Angle Glaucoma.
IncorrectC. Cyclobenzaprine, also known as Flexeril, is a muscle relaxant used in treatment of muscle spasms. It works by decreasing somatic motor activity by inhibiting tonic activity of alpha and gamma neurons. Caution as this medication may cause Narrow Angle Glaucoma.
-
Question 3 of 7
3. Question
All of the following are adverse effects from chronic use of Phenothiazines, EXCEPT:
CorrectB. Phenothiazines, a class of Antipsychotics, function as dopamine receptor antagonists (anti dopamine). Adverse effects include: Parkinson-like symptoms (recall TRAP), Pigmentation effects (pigment on endo, ASC, and HYPERpigmentation of RPE), Oculogyric Crisis.
IncorrectB. Phenothiazines, a class of Antipsychotics, function as dopamine receptor antagonists (anti dopamine). Adverse effects include: Parkinson-like symptoms (recall TRAP), Pigmentation effects (pigment on endo, ASC, and HYPERpigmentation of RPE), Oculogyric Crisis.
-
Question 4 of 7
4. Question
Methylphenidate is commonly used in the treatment of what condition?
CorrectD. Methylphenidate, also known as Ritalin, is commonly used in treatment of ADHD, narcolepsy, and depression. Methylphenidate works by increasing release of dopamine. When given in high doses and/or chronically, mydriasis and dry eye disease may occur. Use with caution in patients with Narrow Angles.
IncorrectD. Methylphenidate, also known as Ritalin, is commonly used in treatment of ADHD, narcolepsy, and depression. Methylphenidate works by increasing release of dopamine. When given in high doses and/or chronically, mydriasis and dry eye disease may occur. Use with caution in patients with Narrow Angles.
-
Question 5 of 7
5. Question
Which of the following medications is commonly used in treatment of Alzheimer’s?
CorrectA. Donepezil, also known as Aricept, is used to treat Alzheimer’s. It functions by inhibiting CNS acetylcholinesterase. Adverse effects include cataracts, blur, and ocular irritation. Aricept has been known to reduce intraocular pressure which may rebound with cessation of medication.
IncorrectA. Donepezil, also known as Aricept, is used to treat Alzheimer’s. It functions by inhibiting CNS acetylcholinesterase. Adverse effects include cataracts, blur, and ocular irritation. Aricept has been known to reduce intraocular pressure which may rebound with cessation of medication.
-
Question 6 of 7
6. Question
Topiramate is commonly used in the treatment of what condition?
CorrectC. Topiramate is clinically indicated for treatment of epilepsy to prevent seizures. It is important to know this medication as it may lead to blurred vision, diplopia, and nystagmus. More severe adverse effects include choroidal swelling leading to a myopic shift and acute angle closure glaucoma.
IncorrectC. Topiramate is clinically indicated for treatment of epilepsy to prevent seizures. It is important to know this medication as it may lead to blurred vision, diplopia, and nystagmus. More severe adverse effects include choroidal swelling leading to a myopic shift and acute angle closure glaucoma.
-
Question 7 of 7
7. Question
Which of the following drugs may cause aplastic anemia? (PICK 3)
CorrectA/C/D. The three medications that may cause aplastic anemia include: Acetazolamide, Methazolamide, and Chloramphenicol. Additionally, Trimethoprim, Pyrimethamine and Methotrexate may also cause aplastic anemia.
IncorrectA/C/D. The three medications that may cause aplastic anemia include: Acetazolamide, Methazolamide, and Chloramphenicol. Additionally, Trimethoprim, Pyrimethamine and Methotrexate may also cause aplastic anemia.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Answered
- Review